Liquidia

LQDANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$8.023 B

$90.22 +0.90%

Close of 7 Aug 2026

Revenue

$158.3M

#2382 by revenue

Earnings

-$68.9M

Loss-making

Shares outstanding

88,928,099

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#42Crinetics PharmaceuticalsCRNX$8.92B
#43AlkermesALKS$8.25B
#44LiquidiaLQDA$8.02B
#45Rhythm PharmaceuticalsRYTM$7.96B
#46Tg TherapeuticsTGTX$7.62B

Where these numbers come from

Share counts and financials for Liquidia are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.